The microbiome of the female reproductive tract has implications for women's reproductive health. We examined the vaginal microbiome in two cohorts of women who experienced normal term births: a cross-sectionally sampled cohort of 613 pregnant and 1,969 non-pregnant women, focusing on 300 pregnant and 300 non-pregnant women of African, Hispanic or European ancestry case-matched for race, gestational age and household income; and a longitudinally sampled cohort of 90 pregnant women of African or non-African ancestry. In these women, the vaginal microbiome shifted during pregnancy toward Lactobacillus-dominated profiles at the expense of taxa often associated with vaginal dysbiosis. The shifts occurred early in pregnancy, followed predictable patterns, were associated with simplification of the metabolic capacity of the microbiome and were significant only in women of African or Hispanic ancestry. Both genomic and environmental factors are likely contributors to these trends, with socioeconomic status as a likely environmental influence.
G rowing evidence suggests that the impact of the vaginal microbiome extends to the health of pregnant women and their neonates in utero and beyond. The vaginal microbiome consists of a finite number of discrete microbial communities dominated by different bacterial taxa or combinations thereof 1, 2 . A vaginal microbiome with microbial communities dominated by species of Lactobacillus has been associated with adverse conditions of health of the female reproductive tract, whereas a microbiome dominated by complex microbial communities of Gardnerella, Atopobium, Dialister, Peptoniphilus, Lachnospiraceae members (bacterial vaginosis (BV)-associated bacterium 1 (BVAB1)) and other anaerobes [3] [4] [5] has been associated with a higher risk. A complex vaginal microbiome is associated with BV, the most common gynecological condition of women of reproductive age 6 , as well as a higher risk of sexually transmitted infection, pelvic inflammatory disease and adverse pregnancy outcomes including preterm birth (PTB) 3, 5, 7 .
More than 10% of neonates in the United States are delivered preterm (<37 weeks' gestation), and certain racial and ethnic groups have even higher rates [8] [9] [10] . Women of African ancestry in the United States are significantly more likely than women of European ancestry to have a premature birth or experience very preterm delivery (<32 weeks' gestation). This health disparity could be due to differences in the vaginal microbiomes of these women as the population attributable risk of BV for spontaneous PTB at <32 weeks' gestation has been estimated to be ~40% 11. Although environmental factors, including socioeconomic status (for example, household income, access to care and so on) are known to contribute to these differences, genetic factors also play a role [12] [13] [14] . Recent studies 1, 2, [15] [16] [17] [18] [19] [20] [21] [22] [23] show that the vaginal microbiomes of women of African ancestry are less likely to be dominated by species of Lactobacillus, and more likely to comprise primarily Gardnerella vaginalis, Atopobium vaginae, Sneathia amnii, BVAB1 and other anaerobes. Independent of the Here, we report an analysis of data from a collaborative effort under the umbrella of the National Institutes of Health Human Microbiome Project phase 1 (HMP1) 24 and the integrative HMP (HMP2) 25 . In our HMP1 study, the Vaginal Human Microbiome Project (VaHMP), we collected more than 40,000 vaginal, cervical, introital and buccal swab samples cross-sectionally from a racially diverse cohort of 4,851 women visiting VCU Medical Center women's clinics (Fig. 1a) . In our HMP2 study, the Multi Omic Microbiome Study: Pregnancy Initiative (MOMS-PI), we collected more than 200,000 vaginal, buccal, rectal, birth product and other samples longitudinally from a racially diverse cohort of 1,572 women and neonates during and after their pregnancies from VCU Medical Center Clinics and clinics associated with the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) in Seattle (Fig. 1b) . We present our findings from women in these two cohorts who experienced uncomplicated term birth (>37 weeks' gestation). The samples were analyzed by 16S ribosomal RNA taxonomic profiling, metagenomic and metatranscriptomic sequencing, and metabolic pathway analysis to track dynamics of the vaginal microbiome through pregnancy. Our results show that the vaginal microbiome changes during normal pregnancy, becoming more Lactobacillusdominated at the expense of G. vaginalis and other anaerobes. These changes are most significant in women of African ancestry, occur early in pregnancy, and seem to be the result of stabilization of Lactobacillus colonization and destabilization of colonization by other taxa. Pathway profiles generated from our metagenomic and metatranscriptomic data confirmed a transition early in pregnancy.
Together, these observations suggest that the compositions of the vaginal microbiomes of women of African and non-African ancestry respond differently during pregnancy due to complex interactions between human and microbial physiology and environmental influences.
Results
Pregnancy alters vaginal microbiome profiles. We generated vaginal microbiome profiles from 613 pregnant and 1,969 nonpregnant apparently healthy women from the VaHMP study as previously described 15, 26, 27 (Supplementary Table 1a and Fig. 2a) . The results suggested that pregnant women have a significantly higher (P < 0.01) prevalence of the four most common Lactobacillus vagitypes (L. crispatus, L. iners, L. gasseri and L. jensenii) and a commensurately lower prevalence of vagitypes dominated by other taxa. The primary driver of these differences was a higher (P < 0.01) prevalence of the L. iners-dominated vagitype in pregnancy at the expense of G. vaginalis and more complex vagitypes. Interestingly, incidence of BVAB1 vagitypes, a taxon associated with risk of BV and PTB 7, 28, 29 , did not decrease in pregnant women. The alpha diversity of the profiles of these pregnant women was also lower than that of non-pregnant women (P < 0.01, Extended Data Fig. 1a ). These observations suggest that a pregnancy-related physiological or environmental influence change in the vagina is conducive to a less complex microbiota. To further explore these observations, we compared the vaginal microbiome profiles of 300 pregnant and 300 non-pregnant case-matched women (Supplementary Table 1b and Fig. 2b ). As expected from the above-noted results, pregnant women were significantly (P < 0.01) more likely to have vagitypes of lactobacilli, with a higher predominance (P < 0.01) of the L. iners vagitype, and a commensurately lower prevalence of the G. vaginalis vagitype (P < 0.05) and other microbiome profiles. A taxon-specific analysis of these profiles confirmed a significantly higher abundance of L. iners and lower abundance of L. crispatus, G. vaginalis, A. vaginae, S. amnii, Prevotella cluster 2, Prevotella bivia and so on (Fig. 2f and Supplementary Table 2) . Again, BVAB1 vagitypes were not affected by pregnancy. The alpha diversity of the profiles of pregnant women in this cohort was significantly lower than that of non-pregnant women (P < 0.01, Extended Data Fig. 1b) .
Shifts in the vaginal microbiome in pregnancy are most pronounced in women of African ancestry. Owing to the overlap between the taxa of higher prevalence in women of African ancestry and taxa that are decreased in abundance in pregnancy, we examined the vaginal microbiome profiles of pregnant and non-pregnant women of different ancestries (Extended Data Fig. 2) . Stratification of the profiles of our non-case-matched cohort according to selfreported ancestry revealed minimal differences in the microbiome profiles of pregnant and non-pregnant women of European ancestry (Extended Data Fig. 2b ). However, pregnant women of African and Hispanic ancestry showed a higher (P < 0.01) prevalence of vagitypes dominated by the four most prevalent Lactobacillus species than their non-pregnant counterparts (Extended Data Fig. 2a,c) . Similarly, no vagitype exhibited a significant difference in pregnant and non-pregnant women of European ancestry (Extended Data  Fig. 2b) , and the higher prevalence of the L. iners vagitype identified in the overall cohort (Fig. 2b) was driven by the higher prevalence (P < 0.01) of this vagitype in women of African ancestry. This difference was coupled with a lower prevalence (P < 0.01) of the G. vaginalis vagitype specific to this racial group (Extended Data  Fig. 2a ). Pregnant Hispanic women also exhibited an increased, but not quite significant, prevalence of the four Lactobacillus vagitypes. Notably, despite the lack of significant differences in the prevalence of specific vagitypes in women of European and Hispanic ancestry, the alpha diversities of the vaginal microbiomes of pregnant women in all groups were lower (P < 0.01) than those of their non-pregnant Articles Nature MediciNe counterparts (Extended Data Fig. 1a) . Interestingly, the alpha diversity of women of African ancestry was consistently greater than that of women of other ancestries (Extended Data Fig. 1c) , independent of pregnancy status. These observations are consistent with the concept that pregnancy both favors taxa of Lactobacillus at the expense of other taxa and presents an environment conducive to a vaginal microbiome of reduced complexity. Analysis of the case-matched cohorts of African, European and Hispanic ancestry confirmed that the differences in the profiles of the overall cohort were driven by significantly higher (P < 0.01) prevalence of Lactobacillus vagitypes with commensurately lower prevalence of other vagitypes in women of African and Hispanic ancestry (Fig. 2c,e) . Women of European ancestry exhibited no significant alteration of vagitype associated with pregnancy (Fig. 2d) , despite a trend toward a higher prevalence of L. iners at the expense of L. crispatus. The trends toward a higher prevalence of L. iners vagitypes and a lower prevalence of G. vaginalis vagitypes observed in the non-racially stratified group above were also observed in pregnant women of African and Hispanic ancestry, although these changes did not reach significance. All of the groups exhibited an enhanced prevalence of the L. iners vagitype in pregnancy.
A taxon-level analysis of the microbiome profiles of all women (Fig. 2f) Profiles were generated by 16S rRNA taxonomic classification and sorted into vagitypes representing the most dominant taxon present in the profile as previously described 15, 26, 27 . The legend is shown for a-e. Blue bars above the charts (a-e) indicate samples with Lactobacillus-dominated vagitypes. b, Microbiome profiles of a subset of 300 pregnant and 300 non-pregnant women from the VaHMP, case-matched for self-identified race, age and socioeconomic status. c, Microbiome profiles of 156 pregnant and 156 non-pregnant women of African ancestry from the VaHMP and case-matched for age and socioeconomic status. d, Microbiome profiles of 61 pregnant and 61 non-pregnant women of European ancestry from the VaHMP and case-matched for age and socioeconomic status. e, Microbiome profiles of 83 pregnant and 83 non-pregnant women of Hispanic ancestry from the VaHMP and case-matched for age and socioeconomic status. f-h, Taxon abundance differences in pregnant and non-pregnant women from b-e. Colored boxes (red and blue) indicate significant (q < 0.05 in two-sided MannWhitney U test after correction for false discovery rate (FDR)) differences in the abundance of that taxon between samples in women who are pregnant or not, respectively. Sample sizes for pregnant/non-pregnant cohorts are listed above each plot. Gray boxes indicate differences that are not significant. Table 2 ). Again, BVAB1 showed no significant change in abundance during pregnancy in these groups. The alpha diversity of the vaginal microbiomes of pregnant women in the overall case-matched cohort was significantly lower (P < 0.01, Extended Data Fig. 1b) . The alpha diversities of the microbiome profiles of pregnant women of African and Hispanic ancestry were also significantly lower (P < 0.05), but pregnant women of European ancestry showed a non-significant difference.
Vaginal microbiomes of women of African ancestry shift early in pregnancy. We characterized the vaginal microbiomes in 90 pregnant women from the MOMS-PI study, 49 of African ancestry and 41 of European ancestry, who delivered at term (>37 weeks' gestation, Supplementary Table 1c) . Overall, these women displayed an array of vagitypes reminiscent of those observed in the VaHMP study (Extended Data Fig. 3a) , and the combined profiles of samples from women of African and non-African ancestry (Extended Data Fig. 3b ) showed differences reflecting those described above (Fig. 2) . Thus, pregnant women of African ancestry displayed significantly (P < 0.01) lower representation of the L. crispatus, L. gasseri and L. jensenii vagitypes, and higher (P < 0.01) representation of L. iners and BVAB1 vagitypes. Variability in women of African ancestry was driven by BVAB1 and L. iners, whereas variability in women of nonAfrican ancestry was driven by L. crispatus and L. iners (Extended Data Fig. 3d ). Again, pregnancy had no significant effect on prevalence of the BVAB1 vagitype. The differences between women of African and non-African ancestry were also clearly reflected in the significantly (P < 0.01) higher alpha diversity of samples from women of African ancestry (Extended Data Fig. 3c ).
Samples collected longitudinally across these pregnancies suggested that pregnant women of African ancestry transition to Lactobacillus-dominated vagitypes, often to a L. iners vagitype (Fig. 3a) . Prevalence of Lactobacillus-dominated profiles in women of African ancestry was lower in the first than in later trimesters, whereas women of European ancestry had a higher prevalence of Lactobacillus vagitypes throughout pregnancy. Women of African ancestry showed significantly (P < 0.05) increased prevalence of the L. iners vagitype, and a decrease of G. vaginalis and other vagitypes often associated with dysbiotic conditions. Women of non-African ancestry, who were over 75% dominated by Lactobacillus vagitypes early in pregnancy, showed no significant changes in vagitypes across pregnancy.
By the second trimester, the composition of the vaginal microbiomes of pregnant women of African ancestry shows an increased prevalence of taxa of Lactobacillus driven by an increase in predominance of the L. iners vagitype (Fig. 3b,c and Extended Data Fig. 4 ). In the first trimester, the alpha diversity of the vaginal microbiomes of women of African ancestry was greater (P < 0.05) than that of other women, but conversion to a more Lactobacillus-dominated profile as pregnancy progressed was accompanied by a significant (P < 0.05) decrease in the alpha diversity and the number of taxa present that no longer differed significantly from that of women of non-African ancestry (Extended Data Fig. 4b ). In contrast, the alpha diversity of women of non-African ancestry was low and showed no significant variation throughout pregnancy (not shown). Taxon-specific analysis confirmed that, as for the cross-sectional cohort, L. iners was more abundant (P < 0.05, Extended Data Fig. 5 ), and G. vaginalis and A. vaginae were significantly (P < 0.05 and P < 0.01, Extended Data Fig. 5a ) less abundant late in pregnancy in women of African ancestry. Other taxa (for example, Prevotella cluster 2, S. amnii and TM7), following the significant trends of the more numerous participants in the cross-sectional analyses described above, were likewise less abundant late in pregnancy in women of African ancestry, although the difference did not reach significance in this smaller cohort (Extended Data Fig. 5b ).
Thus, the differences in the vaginal microbiomes of pregnant women are driven by changes that occur early in pregnancy in women of African ancestry. Many of the taxa decreased in pregnancy (that is, G. vaginalis, A. vaginae, Prevotella cluster 2, S. amnii and TM7) are associated with BV, pelvic inflammatory disease, sexually transmitted infections, risk of preterm birth and other adverse conditions of the female reproductive tract 3, [5] [6] [7] .
Microbiome transitions during pregnancy follow predictable patterns. Prevalence of a vagitype is a product of the stability of that community, the lack of stability of other vagitypes and the probabilities of switching among different dominant communities. Figure 4 shows that vagitypes dominated by lactobacilli, in particular L. crispatus, were quite stable across pregnancy. Other vagitypes (for example, G. vaginalis) exhibited less stability. Figure 4c illustrates longitudinal beta diversity measures of the samples within each participant across pregnancy. For example, samples from women with microbiomes dominated by L. crispatus at first visit are highly similar to subsequent samples collected across pregnancy, but higher instability was observed in other vagitypes (KruskalWallis; P < 0.05). Stability of vagitypes examined only in women of African ancestry or in women of non-African ancestry differed but did not reach significance (not shown).
Tracking of the microbiome profiles of individual women through pregnancy ( Table 1 fits a Markov chain model to these transitions, providing the probability that a vagitype will remain constant or transition over a 90-d window. Our initial effort modeled five vagitype groups, one consisting of L. crispatus, L. gasseri and L. jensenii as a 'Lacto' group, and four others; that is L. iners, G. vaginalis, BVAB1 and 'other' vagitypes often associated with vaginal dysbiosis. In this model, the Lacto group had an ~75% probability of not transitioning. The L. iners vagitype was also stable (~71%), and its most common transition (~19%) was to the 'other' category. BVAB1-dominated vagitypes had lower stability (~58%), most often changed to L. iners vagitypes (~25%) and rarely (4%) changed to the Lacto group vagitypes. G. vaginalis vagitypes were unstable; nearly 80% underwent transition, usually (~74%) to L. iners, BVAB1 or the 'other' vagitypes and only infrequently (~5%) to the Lacto group. The 'other' vagitypes usually (84%) remained vagitypes often associated with dysbiosis; only ~16% transitioned to Lacto group vagitypes.
Owing to the lower numbers of women in the African and nonAfrican groups, we collapsed the vagitypes into three groups (Lacto, L. iners and 'other'), rationalizing that G. vaginalis and BVAB1 could group with 'other' taxa as they are all often associated with dysbiosis. In this model, the Lacto and L. iners vagitypes were quite stable (~75% and ~71%, respectively), but the 'other' group tended to remain in this higher diversity category (53%) or transition to the L. iners vagitype (34%), and only infrequently transitioned to the more protective Lacto group vagitypes (~13%). These trends held in both groups of women (Table 1c, Articles Nature MediciNe (about ninefold and about sevenfold, respectively) to transition to the Lacto vagitypes. Conversely, women of African ancestry with L. iners vagitypes were threefold more likely to transition to an 'other' vagitype. Although these transitions failed to reach significance due to relatively low numbers, women of African ancestry underwent significantly (P < 0.05) more transitions over pregnancy than other women. Together, these observations may explain the prevalence of dysbiosis-linked vagitypes in women of African ancestry; Articles Nature MediciNe that is, women of African ancestry seem to be less likely to transition from dysbiosis-linked vagitypes to 'Lacto' vagitypes and more likely to transition from 'Lacto' vagitypes to vagitypes more often associated with dysbiosis.
The functional potential of the vaginal microbiome changes early in pregnancy. Metagenomic and metatranscriptomic taxonomic profiles of the vaginal microbiomes of women in this study largely recapitulated the vagitypes (Fig. 5a,b,d-f) . However, G. vaginalis transcripts unexpectedly seemed to predominate over transcripts from BVAB1 and other taxa (Fig. 5f ), suggesting that G. vaginalis is more transcriptionally active. Analysis of pathways predicted from the metagenomic and metatranscriptomic sequence data (Fig. 5c,g,h ) and analysis by sparse partial least squares discriminant analysis (PLS-DA; Extended Data Fig. 7a,b) largely reflected the vagitypes in these samples. Whereas L. crispatus and L. iners showed discrete clusters in both metagenomic and metatranscriptomic pathway data, other vagitypes exhibited less discrete overlapping groups. Heat maps of the pathway analysis also resolved the vagitypes (Extended Data Fig. 7c,d) . A pathway centric analysis of the metagenomic data (Supplementary Table 3 ) identified only ten largely unrelated pathways that significantly (P < 0.05) discriminated ancestry, likely due to the substantial partitioning of the vaginal microbiomes of women of both African and non-African ancestry into relatively discrete community states or vagitypes. However, analysis of the metatranscriptomic data identified eight pathways associated with nucleotide metabolism that were significantly (P < 0.05) less prevalent in the more complex microbial communities in women of African ancestry. Analysis of metabolic capacity of the microbiomes across trimesters showed 17 pathways significantly (P < 0.05) reduced, and 90 of 94 abundant pathways reduced in prevalence between trimesters 1 and 2. Only two pathways were significantly (P < 0.05) more reduced in prevalence between trimesters 2 and 3. Thus, the most prevalent changes in the functional microbiome occur by the first trimester. Of the 17 pathways significantly less prevalent in pregnancy, 5 were associated with protein synthesis, 5 with carbohydrate metabolism and cell wall synthesis, 4 with nucleotide metabolism, and 3 with coenzyme A and other cofactor biochemistry. Thus, pregnancy is associated with a simplification of the metabolic capacity of the resident vaginal microbiome, consistent with a transition toward a less complex Lactobacillus-dominated microbiome.
Noting a discrete pattern of pathways in L. crispatus-dominated vagitypes (Fig. 5c,g,h) , we directly compared the pathways of L. crispatus vagitypes to those of other major vagitypes (Supplementary Table 3 ). The L. iners vagitype showed the fewest significant differences (P < 0.05), mostly in pathways associated with cell wall/ membrane biochemistry. G. vaginalis, BVAB1, 'no type' and 'all other' vagitypes differed significantly (P < 0.05) in many pathways (for example, carbohydrate metabolism, cell wall/membrane biochemistry, nucleotide metabolism) from the L. crispatus vagitype. Many of the pathways (for example, carbohydrate metabolism, cell wall/ envelope biochemistry, protein synthesis and nucleotide metabolism) that differed significantly (P < 0.05) between the L. crispatus vagitypes and the G. vaginalis, BVAB1, 'no type' and 'all other' vagitypes, were common. The majority of the pathways, except those associated with l-lysine biosynthesis, UDP-N-acetyl-d-glucosamine biosynthesis and acetylene degradation, were less prevalent in L. crispatus vagitypes than in other microbiome profiles. These observations are consistent with the sparse PLS-DA analysis of pathways (Extended Data Fig. 7a,b) , which showed a significant overlap of the G. vaginalis, BVAB1, 'no type' and 'all other' vagitypes.
Strains of G. vaginalis show racial and taxonomic proclivities.
Bacterial strains of the same species often exhibit significant sequence heterogeneity. G. vaginalis is now subclassified into at least four clades exhibiting nucleotide sequence divergence of ~4 to 20% [30] [31] [32] [33] . Examination of our metagenomic data using PanPhlAn 34 readily discriminated the four major clades of Gardnerella (Extended Data Fig. 8 and Supplementary Table 4) . G. vaginalis clade 4 was most common, but clade 3 was tightly associated with BVAB1 (P < 0.01, see Methods), and was detected only in vaginal microbiomes with BVAB1 concurrently or at a previous or subsequent sampling. Although BVAB1 is found primarily in women of African ancestry, the correlation between G. vaginalis clade 3 and African ancestry was not significant, perhaps because there are many women of this ancestry whose microbiomes lack BVAB1. However, 10 of 11 women with clade 3 were of African ancestry, suggesting a linkage between this clade and ancestry. No other G. vaginalis clade showed a strong linkage to any other taxon or racial group. Since both BVAB1 and G. vaginalis are associated with higher risk of adverse reproductive health effects 7, 28, [35] [36] [37] and both are prevalent in women of African ancestry, the apparent linkage between BVAB1 and G. vaginalis clade 3 may be relevant to racioethnic disparities in women's reproductive health.
These analyses also revealed discrete but previously uncharacterized clades of L. crispatus, L. jensenii, L. gasseri, L. iners and BVAB1 (Extended Data Fig. 8) . We observed no relationship between these clades and any other parameter, although, strain-level discrimination 15 of non-pregnant women indicated that race has a stronger association with diversity of the vaginal microbiome than socioeconomic status. Thus, although we were unable to completely Articles Nature MediciNe decouple race from socioeconomic status herein, we believe both have an impact.
Our longitudinal analysis argues that the transitions of the vaginal microbiomes occur early in pregnancy. Stout et al. 38 reported a decrease in richness and diversity early in pregnancy in the vaginal microbiomes of predominantly African American women who would later deliver preterm. However, in that study of only 149 longitudinal samples from 77 women, no change was observed in women who would deliver at term. DiGiulio et al. 39 reported a stable pregnancy microbiome of the gut, saliva and mouth, and in contrast to results reported herein, the vagina. The cohort of women in that project was predominantly (22 of 34) self-reported as 'White' with only 1 woman self-reported as 'Black' . Goltsman et al. 40 , following ten white pregnant women (six who delivered term and four who delivered preterm), presented data that suggest stability of the vaginal microbiome in pregnancy, although four of the women with vaginal microbiomes initially dominated by L. iners showed an increase in diversity with gestation. Together, these results are largely consistent with our observation that vaginal microbiome changes are most significant in women of African ancestry.
It appears that changes occurring during pregnancy may render the reproductive tracts of women of all racial backgrounds more hospitable to taxa of Lactobacillus and less favorable for G. vaginalis and other taxa associated with BV and dysbiosis. Since the changes are generally toward a microbiome composition resembling that of non-pregnant women of European ancestry, it is not surprising that the shifts are more striking in women of African and Hispanic ancestry. As we and others have speculated 7, 16, 17, 41, 42 , hormonal and other physiological changes in pregnancy may promote a vaginal environment conducive to a less dysbiotic vaginal microbiome. We previously demonstrated 43 that non-pregnant women taking combined oral contraceptives have vaginal microbiome profiles with a higher predominance of Lactobacillus taxa, and several studies by others [44] [45] [46] [47] have shown that post-menopausal women receiving hormone replacement therapy tend to have a more Lactobacillusdominated microbiome. Elevated estrogens in pregnancy enhance glycogen synthesis in the vaginal epithelium. Although most lactobacilli lack alpha-amylase, human enzymes and other bacterial pathways process glycogen into compounds (for example, maltose, maltotriose, maltopentaose and maltodextrins) that are fermented by these bacteria 48 . Thus, Lactobacillus are apparently selectively enriched, to the detriment of other microbial taxa, in pregnant women. Interestingly, BVAB1, which has been associated with dysbiotic vaginal conditions and risk of PTB 7, 28, 29 , and which is present as a major vagitype largely in women of African ancestry, is not noticeably decreased in prevalence in pregnancy. Thus, BVAB1, for reasons yet to be determined, is apparently resistant to factors sculpting the microbiome in pregnant women, possibly explaining in part the enhanced risk for PTB experienced by women of African ancestry.
We and others 1,2,15-23 have previously shown that vaginal microbiomes of non-pregnant women of European ancestry are less complex than those of non-pregnant women of African ancestry. However, the differential impact of pregnancy on the vaginal microbiomes of women of diverse ancestry has not been comprehensively explored. An early cross-sectional study by Aagaard et al. 49 probed the microbiomes of 24 pregnant and 60 non-pregnant women and found that, in pregnancy, the vaginal microbiome is reduced in complexity and enriched in species of Lactobacillus. Walther-Antonio et al. 41 and Romero et al. 42 followed 8 pregnant women and 22 pregnant/32 non-pregnant women, respectively, and also concluded that lactobacilli dominate the vaginal microbiome during pregnancy. MacIntyre et al. 16 , in a longitudinal study of a British cohort of 42 pregnant women who experienced term birth, and Freitas et al. 50 in a cross-sectional study of 182 pregnant and 310 non-pregnant Canadian women, reported reduced diversity and higher prevalence of lactobacilli in vaginal microbiomes during pregnancy. Although these studies are consistent with the results reported herein, numbers of participants were quite modest, non-pregnant case-matched controls were often not available, taxon-specific changes other than Lactobacillus species were generally not addressed, and variables associated with race and ethnicity were usually not explored.
In our study, taxa that are decreased in prevalence in pregnancy include G. vaginalis, A. vaginae, S. amnii, Prevotella cluster 2, P. bivia and others. Many of these taxa have been associated with adverse health conditions, including BV, susceptibility to sexually transmitted infections and human immunodeficiency virus, and adverse pregnancy outcomes including preterm birth 7, 28, [35] [36] [37] . Thus, our results are suggestive of a relationship between physiological changes occurring during pregnancy and the development of a less dysbiotic vaginal microbiota (that is, a more disease-resistant state).
Our examination of the probability of transitions among vagitypes provides clues to the reasons that women of African ancestry generally have more complex vaginal microbiome profiles. Thus, the more favorable Lactobacillus vagitypes (that is, the L. crispatus, L. jensenii and L. gasseri vagitypes) are more stable, and transition to those vagitypes is less common in women of African ancestry. In contrast, vagitypes associated with dysbiosis (BVAB1, G. vaginalis, A. vaginae, S. amnii and other vagitypes) are less stable and transition to other vagitypes at a higher rate. Moreover, transitions from dysbiotic vagitypes to favorable vagitypes are more frequent in women of non-African ancestry. As a result, women of African ancestry are more likely to have a dysbiotic vagitype than women of non-African ancestry. These observations are reminiscent of Gajer et al. 17 , who in a study of 32 non-pregnant reproductive age women reported that vaginal communities dominated by Lactobacillus species were quite stable in contrast to more complex vaginal microbiomes, although that report did not focus on differences in transition rates associated with ancestry or pregnancy. The fact that the directions of these microbiome transitions are similar in pregnant and non-pregnant women suggests that the forces driving them may be related.
Metagenomic analysis illustrated minimal differences in metabolic potential associated with the overall vaginal microbiomes of women of African and non-African ancestry. In contrast, our metatranscriptome analysis identified pathways associated with nucleotide metabolism that are less prevalent in women of African ancestry. This result is consistent with a hypothesis suggesting that a more complex microbiome may be associated with greater damage to the vaginal epithelium, which may release metabolic precursors (for example, nucleotides and nucleotide precursors) that could be scavenged by the vaginal microbiota. Interestingly, nucleotide biosynthesis has been identified as a critical capability for bacterial proliferation in the human bloodstream 51 . It would not be surprising if this were also true in other niches of the human body.
Metagenomic and metatranscriptomic data permitted subspecies classifications. Thus, four previously identified clades of G. vaginalis [30] [31] [32] [33] and two new clades each of L. crispatus, L. jensenii, L. gasseri, L. iners and BVAB1 were discriminated. Clade 3 of G. vaginalis was tightly associated with BVAB1, suggesting a synergistic or symbiotic relationship. Although BVAB1 is highly correlated with women of African ancestry, the relationship between clade 3 of G. vaginalis and race was not significant, probably because many women of African ancestry have microbiome profiles dominated by other taxa. Recently, Janulaitiene et al.
52
, studying a population of 109 non-pregnant women with and without BV, found, as did we, that clade 4 was most common, followed by clade 3, and identified a correlation between clades 1 and 2 and a high Nugent score indicative of BV. Callahan et al.
53
, studying a cohort of 39 pregnancies, 9 of which ended prematurely (<37 weeks' gestation), showed data suggesting an association between a G. vaginalis group, termed G3, that includes isolates from both clades 1 and 2, and preterm Articles Nature MediciNe birth. We have not yet detected a correlation between clades 1, 2 or 4 and any other taxon or clinical condition. However, these observations of close linkage between specific microbial taxa and clinical and demographic phenotypes are suggestive of interdependencies that remain to be elucidated.
The fact that some groups frequently have vaginal microbiome profiles that are clearly associated with dysbiosis, BV and risk of adverse outcomes in pregnancy, including but not limited to preterm birth, underscores the compelling need to further explore these phenomena. That the vaginal microbiomes known to confer higher risk of poor health and adverse outcomes of pregnancy are more highly associated with women of African and Hispanic ancestry, but that pregnancy tends to drive these microbiomes toward more favorable microbiota, suggests that an external intervention that favors this trend might be beneficial for these populations. Characterization of the composition of the vaginal microbiome is now readily achieved. What remains is to verify the most favorable microbiome and the most effective strategy for intervention.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41591-019-0465-8. 24, 25 (https:// commonfund.nih.gov/hmp). All participants in this study were enrolled from visitors to women's clinics in Virginia. All study procedures involving human subjects were reviewed and approved by the Virginia Commonwealth University institutional review board (IRB nos. HM12169 or HM15527). The study was performed in compliance with all relevant ethical regulations. Written informed consent was obtained from all participants and parental permission and assent was obtained for participating minors at least 15 years of age. Women were informed that they could withdraw from the study at any time and that providing samples was at their sole discretion. Women who were incapable of understanding the informed consent or assent forms, or incarcerated were excluded from the study. Comprehensive demographic, health history and dietary assessment surveys were administered, and relevant clinical data (for example, gestational age, height, weight, blood pressure, vaginal pH, diagnosis and so on) were recorded. Relevant clinical information was also obtained from neonates at birth and discharge. At subsequent prenatal visits, triage, in labor and delivery, and at discharge, additional surveys were administered, relevant clinical data were recorded and samples were collected. Vaginal samples were not collected at labor and delivery or at discharge. Women with any of the following conditions were excluded from sampling at a given visit: incapable of self-sampling due to mental, emotional or physical limitations; more than minimal vaginal bleeding as judged by the clinician; ruptured membranes before 37 weeks' gestation; active herpes lesions in the vulvovaginal region. The 2,582 VaHMP cohort was selected according to the following: participants with abnormal discharge, bacterial vaginosis, trichomoniasis, yeast infection, gonorheae, herpes or warts as indicated by the physician at the time of the vist were excluded; in addition, participants with missing clinical data and missing ethinicity information were also excluded.
Articles
Participant/sample selection and case-control design. We analyzed samples from 613 pregnant and 1,969 non-pregnant women with no known health issues who were sampled cross-sectionally in the VaHMP study. A subset of 300 pregnant and 300 non-pregnant women, case-matched for age, race and socioeconomic status, was selected from this group for more detailed analysis. Case-matching was performed blinded to all other study data. From the MOMS-PI study, we selected 90 women, 41 of European ancestry and 49 of African ancestry, who experienced full-term birth at >37 weeks' gestation, reported no known adverse health conditions, and who had samples collected at least one visit per trimester during their pregnancies. These cohorts are briefly described in Supplementary Table 1 .
Sample collection. Samples were collected from consented women at their first visit, either in the VaHMP or MOMS-PI studies, and again longitudinally at each prenatal visit, at triage, and at labor and delivery for women in the MOMS-PI study. Samples were collected with BD BBL CultureSwab EZ swabs. Vaginal samples were collected either by a clinician during a pelvic exam or by selfsampling. Research coordinators instructed the participants on self-sampling procedures, provided a self-sampling instructional brochure, and provided the participant a private room for self-sampling. Self-sampling has been shown to provide results equivalent to those collected by a trained clinician 56 . Samples were collected as follows: a single-or double-tipped CultureSwab EZ swab was placed carefully on the vaginal sidewall about halfway between the introitus and the cervix, pressed firmly into the sidewall to a depth of roughly the diameter of the swab, rolled dorsally-ventrally back and forth four times to coat the swab, and removed. Vaginal pH was collected using commercial applicators with pH paper. Briefly, the applicators were inserted ~1.5-2 inches into the vagina, applied gently to the vaginal wall and withdrawn. The research coordinator compared the color of the pH indicator to a color chart and recorded vaginal pH.
Sample processing. After collection, swabs were immediately immersed in transfer buffer depending on the objectives. Swabs for DNA isolation were immersed in MoBio PowerSoil-htp Bead Solution; swabs for RNA purification were immersed in RNAlater (Qiagen). Swabs were either processed immediately or stored until processing at −80 °C. Swabs for DNA purification were processed using the MoBio PowerSoil DNA Isolation Kit, as described by the manufacturer. Swabs for RNA purification were processed using the MoBio PowerMicrobiome RNA Isolation Kit as described by the manufacturer. Total RNA was depleted of human and microbial rRNA using the Epicentre/Illumina Ribo-Zero Magnetic Gold Kit (Epidemiology) as described by the manufacturer. DNA and RNA samples were stored at −80 °C.
16S rRNA taxonomic surveys of the vaginal microbiome. DNA in each sample was amplified with barcoded primers targeting the V1-V3 region of the 16S rRNA and validated for vaginal taxa essentially as previously reported 7, 26 . The samples were randomized at the PCR stage and again at the sequencing stage. Samples from the VaHMP study were amplified and sequenced on the 454 Titanium Sequencer (Roche) and analyzed as previously described 4 . Samples from the MOMS-PI study were multiplexed (384 samples per run) and sequenced using 2 × 300 base (b) PE technology on our Illumina MiSeq sequencer to generate a depth of coverage of at least 50,000 reads per sample 5 . Briefly, the raw paired-end sequence data were demultiplexed into sample-specific paired-end fastq files based on unique barcode sequences using custom python scripts. The merging of overlapping pairs and quality filtering was performed using the MeFiT 57 pipeline, with a maximum expected error cutoff of 1.0 (Supplementary Table 5 ). Each high-quality amplicon sequence was taxonomically classified to the species level using STIRRUPS 26 , by alignment to a custom reference database of vaginally relevant species. Samples were filtered based on the sequencing depth-samples having fewer than 1,000 high-quality amplicons were removed from further analysis. Taxa assigned belowthreshold by STIRRUPS and less than 0.01% in abundance were also filtered out, and relative proportions were re-computed.
Vagitype assignment and analyses of diversity and richness. Using 16S taxonomic profiles, samples were assigned to vagitypes based on the taxon with the largest proportion of reads and at least 30% representation, essentially as previously reported 26 . Samples with no taxon with over 30% representation were assigned to the 'no type' vagitype. This dataset-independent method of categorizing microbiome profiles has been shown to be in concordance with clustering-based methods 58 . Fisher's exact test was used to assess the differences in proportions of Lactobacillus and non-Lactobacillus vagitypes among samples from pregnant and non-pregnant subjects in Fig. 2a (n = 2,582 , odds ratio = 0.5722). The proportions of L. iners, G. vaginalis, L jensenii, L. gasseri and BVAB1 in pregnant and non-pregnant subjects were also tested using Fisher's exact test with a FDR adjustment using the function p.adjust() in R. The difference in mean diversity between pregnant and non-pregnant subjects was tested using a two-sample t-test (df = 1,758.4, t = 8.1927, n = 2,582). The same tests were used for the case-matched cohorts of 300 pregnant and 300 non-pregnant subjects in Fig. 2b (for the twosample t-test (df = 433.40, t = 5.6252). The Fisher's exact tests and two-sample t-test were applied to the two sets of subjects after stratification by race/ethnicity (for the complete cohort/African/Fisher's: n = 1,488, odds ratio = 0.5454; complete cohort/ European/Fisher's: n = 793, odds ratio = 0.9144, P = 0.7374; complete cohort/ Hispanic/Fisher's: n = 301, odds ratio = 0.4382; complete cohort/African/t-test: df = 698.79, t = 5.616, n = 1,488; complete cohort/European/t-test: df = 250.20, t = 3.2696, n = 793; complete cohort/Hispanic/t-test: df = 165.34, t = 2.011, n = 301; case-match/African/Fisher's: n = 312, odds ratio = 0.5249; case-match/European/ Fisher's: n = 122, odds ratio = 1.0, P = 1.0; case-match/Hispanic/Fisher's: n = 166, odds ratio = 0.2281; case-match/African/t-test: df = 245.13, t = 4.8336, n = 312; case-match/European/t-test: df = 78.589, t = 1.678, n = 122, P = 0.09732; casematch/Hispanic/t-test: df = 110.01, t = 2.8475, n = 166) (Fig. 2c-e) .
Within-sample richness and evenness (beta and alpha diversity) of microbial communities were determined by computing the species count and Shannon index respectively, using vegan in the R statistical package (Extended Data Figs. 3c and 4b). Compositional dissimilarity between samples from each participant was quantified using the Bray-Curtis index (Fig. 4) . To visualize this dissimilarity between samples, we employed L1-norm PCA 54 ordination on square-roottransformed relative abundances using the function sharpel1pcal in the R package pcaL1 (rdrr.io/cran/pcaL1/man/pcaL1-package.html), which is less sensitive to outliers (Fig. 3c) .
Univariate analysis to identify taxa significantly different in abundance in different cohorts (Fig. 2f-I and Supplementary Table 2) . We analyzed vaginal 16S rRNA profiles from pregnant or non-pregnant women of African, Hispanic and European/Non-African ancestry from the VaHMP and MOMS-PI projects to identify taxa significantly enriched in each group. First, from the joint cohorts (n = 600) we removed taxa of low abundance. We used two abundance criteria: we retained taxa for which either 5% of the profiles exhibited an abundance of at least 0.01 (1%), or at least 15% of the profiles exhibited an abundance of at least 0.001 (0.1%). Taxa that failed to meet both criteria were removed. For the remaining taxa, sample abundance values below 0.0001 (0.01%) were rounded to zero. Next, in each ancestry cohort, we performed a Mann-Whitney U test (two-sided) for each taxon to identify significant differences in abundance between pregnant and non-pregnant subjects. Taxa abundance was considered significantly different between cohorts if the q-value was less than a FDR of 5% after correction via the Benjamini-Hochberg 59,60 procedure. For each taxon we also calculated the median and 75th percentile in each of the relevant cohorts. For each box plot, the box indicates the interquartile range and the median is indicated. The whiskers extend to the data point that is at most 1.5 times the interquartile range from the box. In Fig. 1f-I , outlier points are not plotted.
Metagenomic and metatranscriptomic sequencing. Metagenomic and metatranscriptomic sequencing were performed as previously described The P values for all of the coefficients across the models were adjusted using a FDR adjustment implemented in the R function p.adjust(). Differences between trimesters for each pathway were assessed using a post hoc test for estimated marginal means. The function emmeans() in the R package (https://cran.r-project.org/web/packages/emmeans/ emmeans.pdf) was used to test for differences in pathway abundances for each pair of trimesters. The P values from the post hoc tests across all of the pathways were adjusted using a FDR adjustment implemented in the R function p.adjust().
For metatranscriptomic data, linear mixed-effects models were fitted for each pathway to assess the effect of African ancestry and vagitype. P values were adjusted as for the metagenomics data.
Strain association analysis. An analysis was conducted to detect associations between strain groups identified by PanPhlan and environmental factors including ethnic background, trimester and vagitype. The associations were restricted to use only the strain groups as antecedents. Rules were generated with minimum support of 10% (at least 10% of the samples satisfied the rule) and minimum confidence of 60% (confidence: among all subjects with the environmental characteristics, the percentage having a particular strain). An FDR correction for the Fisher's exact test was applied to the generated rules. To confirm the associations and avoid bias from repeated measures, a mixed-effects logistic regression model was fitted with the strain as the response, the environmental variable as a predictor, and a subject random effect.
The R package arules 66 was used to generate and analyze rules. The function glmer() in the R package lme4 65 was used to fit mixed-effects logistic regression models.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
16S rRNA sequence data and metadata for each sample have been deposited in the HMP DACC (https://portal.hmpdacc.org/). Data that are of controlled access (that is, metagenomic and metatranscriptomic sequence data, which can include some sensitive human sequence and subject metadata) have been deposited at NCBI's controlled-access dbGaP (study accession IDs phs001523 and phs000256) and Sequence Read Archive (SRA; BioProject IDs PRJNA326441, PRJNA430481, PRJNA430482, PRJNA74947, PRJNA51443 and PRJNA46877). Additional metadata have been deposited in, and are available through, the RAMS Registry (https://ramsregistry.vcu.edu). Project information is also available at the project website (http://vmc.vcu.edu).
Code availability
Custom code is available at https://github.com/Vaginal-Microbiome-Consortium/ TBS. Open-source software is described in the text.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code Data collection Custom code will be available at https://github.com/Vaginal-Microbiome-Consortium/TBS prior to publication. Open source software is described in the text.
Data analysis
Custom code will be available at https://github.com/Vaginal-Microbiome-Consortium/TBS prior to publication. Open source software is described in the text.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability 16S rRNA sequence data and metadata for each sample are deposited in the HMP DACC (https://portal.hmpdacc.org/). Data that is of controlled-access; i.e., metagenomic and metatranscriptomic sequence, which can included some sensitive human sequence, and subject metadata are deposited at NCBI's controlledaccess dbGaP (study accession IDs: phs001523 and phs000256) and Sequence Read Archive (SRA; BioProject IDs PRJNA326441 and PRJNA46877). Additional metadata is deposited in and available through the RAMS Registry (https://ramsregistry.vcu.edu). Project information is also found in the project website (http:// vmc.vcu.edu).
